Inici › Càncer de pulmó › Pennsilvània › Reading
Assaigs clínics de Càncer de pulmó a Reading, PA
11 estudis de Càncer de pulmó busquen participants en centres de Reading i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutantFase 3
- Reading Hospital, West Reading · a 1 mi
- Ephrata Cancer Center, Ephrata · a 17 mi
- Sechler Family Cancer Center, Lebanon · a 26 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Penn State Health Saint Joseph Medical Center, Reading
- Reading Hospital, West Reading · a 1 mi
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ReclutantFase 3
- Reading Hospital, West Reading · a 1 mi
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ReclutantFase 3
- Ephrata Cancer Center, Ephrata · a 17 mi
- Sechler Family Cancer Center, Lebanon · a 26 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutantFase 3
- Reading Hospital, West Reading · a 1 mi
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ReclutantFase 3
- Reading Hospital - McGlinn Cancer Institute, West Reading · a 1 mi
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ReclutantFase 3
- Reading Hospital, West Reading · a 1 mi
- Ephrata Cancer Center, Ephrata · a 17 mi
- Sechler Family Cancer Center, Lebanon · a 26 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutantFase 2
- Ephrata Cancer Center, Ephrata · a 17 mi
- Sechler Family Cancer Center, Lebanon · a 26 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutantFase 2
- Ephrata Cancer Center, Ephrata · a 17 mi
- Sechler Family Cancer Center, Lebanon · a 26 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutantFase 2/3
- Ephrata Cancer Center, Ephrata · a 17 mi
- Sechler Family Cancer Center, Lebanon · a 26 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
ReclutantEstudi observacional
- US Digestive Health at Wyomissing, Wyomissing · a 2 mi
Assaigs de Càncer de pulmó en altres ciutats
- Houston, TX78 estudis
- Boston, MA62 estudis
- New York City, NY60 estudis
- Los Angeles, CA45 estudis
- Washington, DC41 estudis
- Arlington, VA41 estudis
- Chicago, IL41 estudis
- Nashville, TN40 estudis
- Baltimore, MD40 estudis
- St. Louis, MO39 estudis
- Columbus, OH37 estudis
- Philadelphia, PA36 estudis
Altres estudis a Reading
- Càncer de pulmó de cèl·lules no petites9 estudis
- Leucèmia mieloide aguda5 estudis
- Càncer de mama5 estudis
- Trastorns de somnolència excessiva5 estudis
- Càncer de pròstata4 estudis
- Càncer (tots els tipus)4 estudis
- Càncer colorrectal3 estudis
- Narcolèpsia3 estudis
- Trastorns del son3 estudis
- Fatiga3 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.